Date |
Phase |
Anouncement |
Biotech |
Pharma |
Product |
Disease |
Country |
Other |
2010-04-23 |
II |
Launch |
Affiris (Austria) |
|
vaccine candidate AD02 |
Alzheimer disease |
Austria, Germany, France, the Czech Republic, Slovakia and Croatia |
See details |
2010-04-21 |
II |
Result |
MolMed (Italy) |
|
NGR-hTNF (vascular targeting agent) |
malignant pleural mesothelioma |
|
See details |
2010-04-21 |
II |
Result |
Swedish Orphan Biovitrum (Sweden) |
|
enzyme replacement therapy to improve growth and development in preterm |
enzyme replacement therapy to improve growth and development in preterm infants receiving pasteurized breast milk and/or formula |
|
See details |
2010-04-20 |
Other |
Result |
ThromboGenics (Belgium) |
|
microplasmin |
non surgical treatment of back of the eye disease |
|
See details |
2010-04-19 |
I-IIa |
Launch |
Ark Therapeutics (UK) |
|
EG016 - (AD-VEGF D/adenoviral short-form Vascular Endothelial Growth Factor D gene construct) |
peripheral vascular disease |
Finland |
See details |
2010-04-15 |
Other |
Result |
Active Biotech (Sweden) |
Teva Pharmaceutical (Israel) |
laquinimod |
relapsing remitting multiple sclerosis (RRMS) |
|
See details |
2010-04-15 |
IIa |
Result |
Kenta Biotech (Switzerland) |
|
panobacumab (KBPA101 - fully human IgM monoclonal antibody) |
hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa |
|
See details |
2010-04-15 |
III |
Result |
|
Sanofi-aventis |
lixisenatide (AVE 0010 - once-daily GLP-1 agonist) |
type 2 diabetes |
|
See details |
2010-04-14 |
II |
Launch |
Crucell (The Netherlands) Aeras Global TB Vaccine Foundation |
|
Ad35-AERAS-402 (AdVac®-based tuberculosis vaccine) |
tuberculosis |
South Africa |
See details |
2010-04-13 |
III |
Launch |
MolMed (Italy) |
|
NGR-hTNF (vascular targeting agent) |
malignant pleural mesothelioma |
|
See details |
2010-04-13 |
III |
Result |
|
Novartis (Switzerland) |
Gilenia® (FTY720 - fingolimod) |
multiple sclerosis |
|
See details |
2010-04-12 |
I |
Result |
Nabriva Therapeutics (Austria) |
|
BC-3781 (pleuromutilin antibiotic) |
skin and skin structure infections, community-acquired pneumonia |
|
See details |
2010-04-12 |
I-IIa |
Launch |
SuppreMol (Germany) |
|
SM101 (recombinant soluble non-glycosylated version of the Fc-receptor FcyRIIb) |
idiopathic thrombocytopenic purpura |
Germany, Belgium, Poland, and Russia |
See details |
2010-04-07 |
I-II |
Launch |
Neovacs (France) |
|
IFN alpha-Kinoid® (IFN-K) |
lupus |
France, Belgium an other European countries |
See details |
2010-03-30 |
I-II |
Launch |
Prosensa (The Netherlands) |
|
PRO044 |
Duchenne Muscular Dystrophy |
Belgium, Italy, Sweden |
See details |